Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ASF Mouthrinse on Gingivitis
NCT01317446Phase 4Completed
- Sponsor
- Technische Universität Dresden
- Start
- Nov 2010
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Meridol in gingivitis (2 arms), sponsored by Technische Universität Dresden. Primary endpoint: Reduction in gingivitis at 6 months. Started Nov 2010; status: completed.
02
Drugs
Meridol
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT01317446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01317446.